1. Pharmacodynamic application of l-dopa in cardiogenic shock
- Author
-
Hugo Carrasco, Samuel Meerbaum, Jose R. Lozano, Tzu-Wang Lang, and Eliot Corday
- Subjects
Male ,medicine.medical_specialty ,Time Factors ,Heart Ventricles ,Shock, Cardiogenic ,Blood Pressure ,Stimulation ,Kidney ,Dogs ,Mesenteric Veins ,Heart Rate ,Coronary Circulation ,Internal medicine ,medicine ,Animals ,Beneficial effects ,Aorta ,Coronary flow ,Phenoxybenzamine ,business.industry ,Cardiogenic shock ,Heart ,medicine.disease ,Propranolol ,Dihydroxyphenylalanine ,Mesenteric Arteries ,Disease Models, Animal ,medicine.anatomical_structure ,Regional Blood Flow ,Pharmacodynamics ,Anesthesia ,Cardiology ,Vascular resistance ,Female ,Vascular Resistance ,Cardiology and Cardiovascular Medicine ,business - Abstract
l -dopa was administered to 20 dogs in cardiogenic shock. Beneficial effects were noted three to five minutes after infusion began, but more significant effects were observed within 15 minutes, reaching a maximum 45 to 60 minutes after infusion. The principal changes observed were: (1) a significant increase in coronary flow, (2) a significant rise in left ventricular dp dt max , and (3) a decrease in total peripheral vascular resistance. Aortic and mesenteric flows increased significantly. Renal flow did not improve throughout the l -dopa infusion. l -dopa benefits were probably due to a stimulation of the beta-receptors.
- Published
- 1972
- Full Text
- View/download PDF